Salo-Ahen OMH - Search Results

1

High-Throughput Molecular Dynamics-Based Alchemical Free Energy Calculations for Predicting the Binding Free Energy Change Associated with the Selected Omicron Mutations in the Spike Receptor-Binding Domain of SARS-CoV-2.

Bhadane R, Salo-Ahen OMH. Bhadane R, et al. Among authors: salo ahen omh. Biomedicines. 2022 Nov 1;10(11):2779. doi: 10.3390/biomedicines10112779. Biomedicines. 2022. PMID: 36359299 Free PMC article.

2

The active-inactive transition of human thymidylate synthase: targeted molecular dynamics simulations.

Salo-Ahen OM, Wade RC. Salo-Ahen OM, et al. Proteins. 2011 Oct;79(10):2886-99. doi: 10.1002/prot.23123. Epub 2011 Aug 22. Proteins. 2011. PMID: 21905113

3

Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.

Cardinale D, Guaitoli G, Tondi D, Luciani R, Henrich S, Salo-Ahen OM, Ferrari S, Marverti G, Guerrieri D, Ligabue A, Frassineti C, Pozzi C, Mangani S, Fessas D, Guerrini R, Ponterini G, Wade RC, Costi MP. Cardinale D, et al. Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E542-9. doi: 10.1073/pnas.1104829108. Epub 2011 Jul 27. Proc Natl Acad Sci U S A. 2011. PMID: 21795601 Free PMC article.

4

Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.

Saario SM, Poso A, Juvonen RO, Järvinen T, Salo-Ahen OM. Saario SM, et al. J Med Chem. 2006 Jul 27;49(15):4650-6. doi: 10.1021/jm060394q. J Med Chem. 2006. PMID: 16854070

5

CB receptor ligands from plants.

Woelkart K, Salo-Ahen OM, Bauer R. Woelkart K, et al. Curr Top Med Chem. 2008;8(3):173-86. doi: 10.2174/156802608783498023. Curr Top Med Chem. 2008. PMID: 18289087 Review.

6

Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins.

Mirza MU, Rafique S, Ali A, Munir M, Ikram N, Manan A, Salo-Ahen OM, Idrees M. Mirza MU, et al. Sci Rep. 2017 Apr 11;7:44633. doi: 10.1038/srep44633. Sci Rep. 2017. PMID: 28398303 Free PMC article. No abstract available.

7

Dynamics of CYP51: implications for function and inhibitor design.

Yu X, Cojocaru V, Mustafa G, Salo-Ahen OM, Lepesheva GI, Wade RC. Yu X, et al. J Mol Recognit. 2015 Feb;28(2):59-73. doi: 10.1002/jmr.2412. Epub 2015 Jan 20. J Mol Recognit. 2015. PMID: 25601796 Free PMC article.

8

Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs.

Garg D, Henrich S, Salo-Ahen OM, Myllykallio H, Costi MP, Wade RC. Garg D, et al. J Med Chem. 2010 Sep 23;53(18):6539-49. doi: 10.1021/jm901869w. J Med Chem. 2010. PMID: 20527892 Review. No abstract available.

9

Homodimeric enzymes as drug targets.

Cardinale D, Salo-Ahen OM, Ferrari S, Ponterini G, Cruciani G, Carosati E, Tochowicz AM, Mangani S, Wade RC, Costi MP. Cardinale D, et al. Curr Med Chem. 2010;17(9):826-46. doi: 10.2174/092986710790712156. Curr Med Chem. 2010. PMID: 20156173 Review.

10

Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.

Salo-Ahen OM, Tochowicz A, Pozzi C, Cardinale D, Ferrari S, Boum Y, Mangani S, Stroud RM, Saxena P, Myllykallio H, Costi MP, Ponterini G, Wade RC. Salo-Ahen OM, et al. J Med Chem. 2015 Apr 23;58(8):3572-81. doi: 10.1021/acs.jmedchem.5b00137. Epub 2015 Apr 1. J Med Chem. 2015. PMID: 25798950 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page